VEGFA and renal cell carcinoma: Various diagnostic, prognostic, treatment and predictive biomarkers associated with angiogenesis in RCC have been used, of which VHL and its downstream HIF/VEGF pathway have been well understood, and associated targeted therapy has also been developed.